There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Assertio Therapeutics (ASRT – Research Report), Achieve Life Sciences (ACHV – Research Report) and uniQure (QURE – Research Report) with bullish sentiments.
Assertio Therapeutics (ASRT)
BWS Financial analyst Hamed Khorsand maintained a Buy rating on Assertio Therapeutics today and set a price target of $10.00. The company’s shares closed last Tuesday at $6.98, close to its 52-week high of $7.33.
According to TipRanks.com, Khorsand is a 5-star analyst with an average return of
Currently, the analyst consensus on Assertio Therapeutics is a Strong Buy with an average price target of $9.50, which is a 40.7% upside from current levels. In a report issued on April 26, Lake Street also maintained a Buy rating on the stock with a $8.00 price target.
See today’s best-performing stocks on TipRanks >>
Achieve Life Sciences (ACHV)
In a report released today, Thomas Flaten from Lake Street maintained a Buy rating on Achieve Life Sciences, with a price target of $22.00. The company’s shares closed last Wednesday at $9.35.
According to TipRanks.com, Flaten is a 2-star analyst with an average return of
Achieve Life Sciences has an analyst consensus of Strong Buy, with a price target consensus of $20.50, implying a 132.7% upside from current levels. In a report released today, Ladenburg Thalmann & Co. also maintained a Buy rating on the stock with a $35.00 price target.
uniQure (QURE)
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on uniQure, with a price target of $90.00. The company’s shares closed last Tuesday at $21.79.
According to TipRanks.com, Trucchio ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Currently, the analyst consensus on uniQure is a Strong Buy with an average price target of $57.38, which is a 175.5% upside from current levels. In a report released yesterday, Goldman Sachs also maintained a Buy rating on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ASRT:
- Assertio Reports First Quarter 2023 Financial Results, Raises Full Year 2023 Outlook
- Assertio Holdings, Inc. Updates First Quarter 2023 Financial Results Call Time to Tuesday, May 9, 2023 at 11:30 am Eastern Time
- ASRT Upcoming Earnings Report: What to Expect?
- Assertio Holdings, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023
- Spectrum downgraded to Neutral from Buy at H.C. Wainwright
